Santa Cruz Biotechnology

c-Abl (24-11)

#sc-23 · western blot

92
Citing papers
2.8k
Combined citations
Supplier page Find this product

Research areas

Chronic Myeloid Leukemia Treatments20Eosinophilic Disorders and Syndromes7Protein Degradation and Inhibitors5Chronic Lymphocytic Leukemia Research5Myeloproliferative Neoplasms: Diagnosis and Treatment4HER2/EGFR in Cancer Research3Multiple Myeloma Research and Treatments3Acute Myeloid Leukemia Research3

Papers citing this product

1
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
Blood·2009·398 cit.·DOI
2
Interaction between Protein Kinase C δ and the c-Abl Tyrosine Kinase in the Cellular Response to Oxidative Stress
Journal of Biological Chemistry·2000·206 cit.·DOI
3
High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia
Blood·2011·187 cit.·DOI
4
Activation of the Cytoplasmic c-Abl Tyrosine Kinase by Reactive Oxygen Species
Journal of Biological Chemistry·2000·165 cit.·DOI
5
Selective Ablation of the Androgen Receptor in Mouse Sertoli Cells Affects Sertoli Cell Maturation, Barrier Formation and Cytoskeletal Development
PLoS ONE·2010·163 cit.·DOI
6
Tr‐kit‐induced resumption of the cell cycle in mouse eggs requires activation of a Src‐like kinase
The EMBO Journal·2002·137 cit.·DOI
7
The β-Amyloid Precursor Protein APP Is Tyrosine-phosphorylated in Cells Expressing a Constitutively Active Form of the Abl Protoncogene
Journal of Biological Chemistry·2001·121 cit.·DOI
8
A Novel FRET-Based Biosensor for the Measurement of BCR-ABL Activity and Its Response to Drugs in Living Cells
Clinical Cancer Research·2010·94 cit.·DOI
9
EphA4 Activation of c-Abl Mediates Synaptic Loss and LTP Blockade Caused by Amyloid-β Oligomers
PLoS ONE·2014·88 cit.·DOI
10
Internal Kinematics of Field Galaxies at Intermediate Redshifts
The Astrophysical Journal·1998·80 cit.·DOI